Stock vs Stock Comparison

Henry Schein, Inc. vs Abbott Laboratories

ABT wins the Tale of the Tape 6–3.

HSIC$75.74
ABT$86.99

🏆 Tale of the Tape

36
HSICABT
3.0%Profitability (Net Margin)14.7%
23.1xValuation (P/E)24.0x
6.8%Efficiency (ROIC)10.1%
4/9Health (Piotroski F)5/9
2.7Safety (Altman Z)4.9
4.0%Growth (Rev YoY)5.7%
0.46Risk (Sharpe 1Y)-1.05
1.34xBalance Sheet (D/E)0.64x
4.82%FCF Yield4.21%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.276
252-Day Correlation
0.342
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricHSICABT
Market Cap$8.7B$149.1B
P/E Ratio23.1x24.0x
Forward P/E13.0x14.1x
P/B2.68x2.86x
Dividend Yield2.94%
Beta0.820.65

Quantitative Metrics

MetricHSICABT
DCF Fair Value$130.04$57.20
DCF Upside+71.1%-43.2%
Piotroski F4/95/9
Altman Z2.734.87
Beneish M-2.53-2.53
FCF Yield4.82%4.21%
Net Debt/EBITDA2.2x0.1x
ROIC6.8%10.1%
WACC8.9%9.4%
ROIC – WACC-2.2pp0.7pp
Gross Margin31.1%56.4%
Net Margin3.0%14.7%
Rev Growth YoY4.0%5.7%
Sharpe (1Y)0.46-1.05
Max Drawdown 3Y
FCF Payout Ratio56%

HSIC Price

Loading chart...

ABT Price

Loading chart...

ETF Exposure

HSIC found in:

XHS1.73%
ONEV0.27%
RSP0.19%
VBR0.16%
ONEO0.15%
XLV0.14%
VHT0.13%
VB0.09%
SCHV0.03%
IWD0.03%
SPYV0.03%
SCHX0.01%
IVV0.01%
SCHB0.01%
SPY0.01%
ITOT0.01%
SPLG0.01%
VOO0.01%
SPTM0.01%

ABT found in:

IHI16.06%
IYH2.88%
XLV2.85%
VHT2.55%
DGRW1.71%
XHE1.36%
NOBL1.34%
SDY0.99%
MGV0.78%
VIG0.71%
VFMV0.69%
SCHV0.68%
VYM0.65%
VTV0.61%
IWD0.58%
QUS0.57%
SPYV0.53%
VONV0.48%
IVV0.37%
SPLG0.37%
ESGV0.36%
ITOT0.33%
SCHX0.33%
SCHB0.30%
VOO0.26%
VONE0.24%
SPY0.24%
URTH0.24%
VTI0.23%
SPTM0.22%
ACWI0.20%
RSP0.17%
VT0.14%
ONEO0.08%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

HSIC vs ABT: Head-to-Head Analysis

Henry Schein, Inc. (HSIC) and Abbott Laboratories (ABT) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, ABT leads 6–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, HSIC generates a return on invested capital (ROIC) of 6.8% compared to ABT's 10.1%. This suggests ABT is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between HSIC and ABT is 0.276, indicating low correlation, making them an effective diversification pair in a portfolio context.

HSIC appears in 19 ETFs tracked by SecuritiesDB, while ABT appears in 34 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, HSIC or ABT?

Our quantitative analysis compares HSIC and ABT across nine fundamental dimensions. ABT wins the Tale of the Tape 6–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are HSIC and ABT correlated?

The 252-day correlation between HSIC and ABT is 0.276. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.